Untreated Hypertension Patients At High Risk Of Open-Angle Glaucoma
- byDoctor News Daily Team
- 05 August, 2025
- 0 Comments
- 0 Mins
 
                            
                                    Korea: According to a study published in the American Journal of Ophthalmology, researchers have concluded that the risk of open-angle glaucoma increases with the risk of untreated blood pressure.
Hypertension (HTN) is associated with open-angle glaucoma (OAG). The question is whether elevated blood pressure (BP) alone is associated with OAG.
There needs to be more research and data on Whether stage 1 hypertension increases the disease risk, as per the 2017 American College of Cardiology/American Heart Association (ACC/AHA) BP guidelines.
The researchers in the present retrospective, observational cohort study investigated the above background, including 360,330 subjects ≥40 years and not taking antihypertensive drugs or antiglaucoma drugs at the time of examinations.
The categories of Subjects were untreated BP, into normal BP (systolic BP (SBP)<120 and diastolic BP (DBP)<80 mmHg; n=104,304), elevated BP (SBP 120-129 and DBP<80mmHg; n=33,139), stage 1 HTN (SBP 130-139 or DBP 80-89 mmHg; n=122,534) or stage 2 HTN (SBP≥140 or DBP≥90mmHg; n=100,353).
The study summary is :
Among the participants, 56.2 % were male, with a mean age of 51.17±8.97 years.
The mean follow-up period was 11.76±1.37 years.
Twelve thousand eight hundred forty-one subjects had OAG.
Multivariable-adjusted HRs for elevated BP, stage 1 HTN and stage 2 HTN with normal BP as the reference were 1.056, 1.101 and 1.114, respectively.
Concluding further, they said OAG risk increases with increases in untreated BP.
They mentioned Stage 1 HTN as a significant risk factor for OAG. The study has addressed the role of screening and monitoring for glaucoma in those diagnosed with hypertension.
Further reading:
Increased risks of open-angle glaucoma in untreated hypertension. https://doi.org/10.1016/j.ajo.2023.03.032
                                
    Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
    The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
    Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
    If you come across any inconsistencies, please reach out to us at 
    admin@doctornewsdaily.com.
    We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
    By using this website, you agree to our 
    Terms of Use, 
    Privacy Policy, and 
    Advertisement Policy.
    For further details, please review our 
    Full Disclaimer.
Recent News
Merck Keytruda wins European Commission nod for lo...
- 30 October, 2025
UP NEET 2025 round 3 allotment results postponed
- 30 October, 2025
Achin Gupta to succeed Umang Vohra as Cipla MD, GC...
- 30 October, 2025
Mumbai shocker: KEM Hospital doctor stabbed by col...
- 30 October, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.
 
                     
                    
0 Comments
Post a comment
No comments yet. Be the first to comment!